Savarese, T., Mitchell, K., McQuain, C., Campbell, C., Guardiani, R., Wuu, J., Ollari, C., Reale, F., Nelson, B., Chen, A. and Quesenberry, P. (2001) Coexpression of Granulocyte Colony Stimulating Factor and Its Receptor in Primary Ovarian Carcinomas. Cancer Letters, 162, 105-115.
http://dx.doi.org/10.1016/S0304-3835(00)00623-6

has been cited by the following article:

• TITLE: Ectopic Hormone Production from Ovarian Tumor: A Review

  AUTHORS: Masashi Hori, Hiroshi Takagi, Kazutoshi Matsunami, Satoshi Ichigo, Atsushi Imai

  KEYWORDS: Bioactive Substance Production, Ectopic Hormone Secretion, Ovarian Cancer, Ovarian Carcinoid, Benign Ovarian Tumor

  JOURNAL NAME: Open Journal of Obstetrics and Gynecology, Vol.6 No.4, March 28, 2016

  ABSTRACT: Although ectopic hormone-production is uncommon complication, certain tumors can produce symptoms due to the secretion of various bioactive substances accompanied by the aberrantly located tumors. Because of the potential for the ovary to act as a source of aberrant hormone secretion, in the literature, ectopic hormone production from ovarian tumor includes granulocyte-colony stimulating factor (G-CSF), parathyroid hormone-related protein (PTHrP), adrenocorticotropic hormone (ACTH), peptide-YY, gastrin and insulin. All patients may present with syndromes of hormone excess. Failure to localize the ovarian tumor preoperatively may be associated with a significantly higher risk of subsequent unnecessary ablative procedures. Better characterization of hormonal forms relatively specific for neoplasia may enhance the clinical value of ectopic hormones as tumor markers, especially in malignancies that are commonly associated with ectopic hormone production. These circumstances may recommend complete preoperative evaluation of the pelvis in female patients presenting with nonlocalizable endocrine tumors.